ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Effects of bevacizumab combined with anti-epidermal growth factor receptor monoclonal antibody-targeted drugs in patients with metastatic colorectal cancer.

No numbers read from the abstract.

Not cited yet